| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 0 | 7.486 | 379 | 0 | 2.427 | 26.463 | 32.274 | 14.101 |
| Total Income - EUR | - | - | 0 | 8.226 | 379 | 0 | 2.427 | 26.463 | 32.274 | 14.101 |
| Total Expenses - EUR | - | - | 0 | 39.079 | 382 | 249 | 1.893 | 41.595 | 33.704 | 16.187 |
| Gross Profit/Loss - EUR | - | - | 0 | -30.853 | -3 | -249 | 534 | -15.132 | -1.430 | -2.086 |
| Net Profit/Loss - EUR | - | - | 0 | -30.928 | -14 | -249 | 462 | -15.926 | -1.430 | -2.086 |
| Employees | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Epitome S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 0 | 149 | 146 | 0 | 0 | 0 | 3.398 | 4.005 |
| Current Assets | - | - | 0 | 897 | 1.331 | 1.326 | 965 | 5.612 | 9.770 | 38 |
| Inventories | - | - | 0 | 0 | 0 | 0 | 708 | 0 | 708 | 0 |
| Receivables | - | - | 0 | 897 | 1.331 | 1.326 | 7 | 4.735 | 3.165 | 22 |
| Cash | - | - | 0 | 0 | 0 | 0 | 250 | 877 | 5.898 | 16 |
| Shareholders Funds | - | - | 0 | -44.802 | -43.949 | -43.364 | -41.941 | -15.886 | -1.390 | -2.046 |
| Social Capital | - | - | 0 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | 0 | 45.849 | 45.426 | 44.690 | 42.906 | 21.498 | 14.558 | 6.089 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7311 - 7311" | |||||||||
| CAEN Financial Year |
7311
|
|||||||||
Comments - Epitome S.r.l.